Hydroxypropyl Methylcellulose (HPMC) is a widely used excipient in controlled-release (CR) formulations, known for its ability to modify the release rate of active ingredients in pharmaceuticals, nutraceuticals, and dietary supplements. The unique properties of HPMC, particularly its gel-forming ability, high viscosity, and biocompatibility, make it an ideal choice for creating controlled or sustained-release drug delivery systems.
HPMC, when exposed to body fluids, absorbs water and swells to form a gel layer around the capsule or tablet. This gel acts as a barrier that controls the diffusion of the active ingredient, resulting in a slow and sustained release. By selecting higher viscosity grades like K100, K15M, and E50, manufacturers can further enhance the gel's thickness and the release rate control, which is crucial for extended-release formulations.
In the pharmaceutical field, controlled release technology has become particularly important because it has good biocompatibility and film-forming properties and can better exert its efficacy in drugs. It can ensure that drugs are released in a predictable and sustained manner and improve the degree of drug treatment optimization by 30%-80%. Hydroxypropyl methylcellulose (HPMC) has become the cornerstone of drug-controlled release products due to its excellent performance and versatility.
HPMC is widely used in oral drug formulations. It forms a gel barrier through a hydrogen bond network to accurately control drug release rate, time and location in the gastrointestinal tract, improve drug absorption efficiency and reduce side effects. The principle is to closely combine with the physiological characteristics of the oral environment, such as pH gradient, enzyme activity, intestinal peristalsis, etc.
HPMC film can be used as a coating material for tablets and capsules. When it enters the human body, it hydrates in its environment to form a semipermeable membrane. The drug is released through the pores of the film. The release rate depends on the thickness of the film. Controlling the thickness of the film is crucial for drugs that require long-term stable release.
In transdermal drug delivery, such as nicotine patches, when the patch adheres to the skin, HPMC forms a gel matrix that binds to the moisture in the skin, triggering the controlled release of the drug. Its biocompatibility reduces the risk of skin irritation with transdermal drug delivery.
Based on HPMC’s controlled release function, implantable drug delivery devices can be used in the human body for a long time. They can be designed to release drugs over a long period, provide a targeted and continuous drug supply, and minimize systemic side effects. They are particularly suitable for treating local diseases such as gastritis, pneumonia, and kidney stones.
In short, HPMC is increasingly used in pharmaceutical preparations, and the application ratio has reached 5%- 70% according to different drug types, of which oral solid preparations account for up to 60-70%. With the development of technology, the HPMC-based controlled release system is expected to be further optimized in the future, thereby achieving more effective and suitable drug therapy for patients.
Hydroxypropyl Methylcellulose (HPMC) is a widely used excipient in controlled-release (CR) formulations, known for its ability to modify the release rate of active ingredients in pharmaceuticals, nutraceuticals, and dietary supplements. The unique properties of HPMC, particularly its gel-forming ability, high viscosity, and biocompatibility, make it an ideal choice for creating controlled or sustained-release drug delivery systems.
HPMC, when exposed to body fluids, absorbs water and swells to form a gel layer around the capsule or tablet. This gel acts as a barrier that controls the diffusion of the active ingredient, resulting in a slow and sustained release. By selecting higher viscosity grades like K100, K15M, and E50, manufacturers can further enhance the gel's thickness and the release rate control, which is crucial for extended-release formulations.
Viscosity and Gelation: Higher viscosity grades such as K100 provide strong gel-forming capabilities, creating thicker gels that slow the release of the active ingredient. These thick gels help control the release profile, ensuring a steady and prolonged effect.
Biocompatibility: HPMC is non-toxic and safe for use in pharmaceutical and nutraceutical formulations, ensuring its suitability for long-term use in controlled-release systems.
Water Solubility and pH Independence: HPMC's ability to dissolve in water and form gels at a wide pH range allows for controlled release in various gastrointestinal conditions, making it versatile for different formulations.
Extended Release and Stability: HPMC helps stabilize the active ingredient, providing a controlled and consistent release over an extended period, reducing the frequency of dosing and improving patient compliance.
| Grade | Viscosity Characteristics | Recommended Application | Suitable for Controlled-Release Products |
| K100 | High viscosity | Provides high gel strength for extended-release formulations | Ideal for extended-release capsules and controlled-release tablets |
| K15M | High viscosity | Suitable for high-stability, long-acting formulations | Extended-release drugs, slow-release systems |
| E50 | High viscosity | Excellent for controlling the release of active ingredients | Slow-release capsules and formulations with high viscosity needs |
Pharmaceuticals: Used in medications that require controlled or sustained release, such as pain management drugs, hypertension treatments, or hormone therapies.
Nutraceuticals: Ideal for dietary supplements that require gradual release of active ingredients, like vitamins, minerals, and herbal extracts.
In summary, HPMC's unique gel-forming properties, combined with its versatility and biocompatibility, make it a vital excipient in controlled-release formulations. High viscosity grades such as K100, K15M, and E50 are particularly effective for achieving consistent, long-lasting release profiles, ensuring the stability and efficacy of active ingredients in extended-release systems.
can be selected depending on specific viscosity, dissolution, or stability requirements.
A. The solubility of drugs; B. Properties of HPMC: Different models and specifications of HPMC have different drug release speeds; C. According to the requirements of sustained-release and controlled-release preparations, the content of HPMC in tablets is preferably 20% to 40%, and the specific dosage should be determined through experiments.
HPMC can be made into various forms for drug delivery, such as hydrogels, micelles, microparticles, the skeleton of tablet drugs, or the shell of capsules. All of these have unique properties for drug loading and delivery.
